10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001628280-19-006594 |
| Period End Date | 20190331 |
| Filing Date | 20190510 |
| Fiscal Year | 2019 |
| Fiscal Period | Q1 |
| XBRL Instance | gh-20190331.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
62 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$140.54M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$153.79M | USD | Point-in-time |
| Short-term marketable securities |
MarketableSecuritiesCurrent
|
$278.42M | USD | Point-in-time |
| Short-term marketable securities |
MarketableSecuritiesCurrent
|
$313.07M | USD | Point-in-time |
| Accounts receivable |
AccountsReceivableNetCurrent
|
$28.99M | USD | Point-in-time |
| Accounts receivable |
AccountsReceivableNetCurrent
|
$35.69M | USD | Point-in-time |
| Inventory |
InventoryNet
|
$10.26M | USD | Point-in-time |
| Inventory |
InventoryNet
|
$9.14M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$5.20M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$6.15M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$512.25M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$468.99M | USD | Point-in-time |
| Long-term marketable securities |
MarketableSecuritiesNoncurrent
|
$25.92M | USD | Point-in-time |
| Long-term marketable securities |
MarketableSecuritiesNoncurrent
|
$77.56M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$31.00M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$30.58M | USD | Point-in-time |
| Capitalized license fees |
FiniteLivedIntangibleAssetsNet
|
$7.56M | USD | Point-in-time |
| Capitalized license fees |
FiniteLivedIntangibleAssetsNet
|
$7.80M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$2.86M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$2.05M | USD | Point-in-time |
| Total Assets |
Assets
|
$587.40M | USD | Point-in-time |
| Total Assets |
Assets
|
$579.17M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$10.64M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$7.16M | USD | Point-in-time |
| Accrued compensation |
DeferredCompensationLiabilityCurrent
|
$14.68M | USD | Point-in-time |
| Accrued compensation |
DeferredCompensationLiabilityCurrent
|
$12.99M | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$7.08M | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$9.14M | USD | Point-in-time |
| Capital lease, current |
CapitalLeaseObligationsCurrent
|
$97.00K | USD | Point-in-time |
| Capital lease, current |
CapitalLeaseObligationsCurrent
|
$96.00K | USD | Point-in-time |
| Deferred revenue |
DeferredRevenueCurrent
|
$16.14M | USD | Point-in-time |
| Deferred revenue |
DeferredRevenueCurrent
|
$17.11M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$48.19M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$46.94M | USD | Point-in-time |
| Capital lease, net of current portion |
CapitalLeaseObligationsNoncurrent
|
$119.00K | USD | Point-in-time |
| Capital lease, net of current portion |
CapitalLeaseObligationsNoncurrent
|
$100.00K | USD | Point-in-time |
| Deferred rent, net of current portion |
DeferredRentCreditNoncurrent
|
$7.84M | USD | Point-in-time |
| Deferred rent, net of current portion |
DeferredRentCreditNoncurrent
|
$8.97M | USD | Point-in-time |
| Obligation related to royalty |
AccruedRoyaltiesNoncurrent
|
$7.34M | USD | Point-in-time |
| Obligation related to royalty |
AccruedRoyaltiesNoncurrent
|
$7.12M | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$206.00K | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$150.00K | USD | Point-in-time |
| Total Liabilities |
Liabilities
|
$62.45M | USD | Point-in-time |
| Total Liabilities |
Liabilities
|
$64.54M | USD | Point-in-time |
| Commitments and contingencies (Note 7) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 7) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Redeemable noncontrolling interest |
RedeemableNoncontrollingInterestEquityCarryingAmount
|
$41.80M | USD | Point-in-time |
| Redeemable noncontrolling interest |
RedeemableNoncontrollingInterestEquityCarryingAmount
|
$46.50M | USD | Point-in-time |
| Common stock, par value of $0.00001 per share; 350,000,000 shares authorized as of March 31, 2019 and December 31, 2018; 86,098,474 and 85,832,454 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively |
CommonStockValueOutstanding
|
$1.00K | USD | Point-in-time |
| Common stock, par value of $0.00001 per share; 350,000,000 shares authorized as of March 31, 2019 and December 31, 2018; 86,098,474 and 85,832,454 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively |
CommonStockValueOutstanding
|
$1.00K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$771.01M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$764.03M | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-83.00K | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$333.00K | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-303.21M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-280.80M | USD | Point-in-time |
| Total Stockholders Equity |
StockholdersEquity
|
$308.61M | USD | Point-in-time |
| Total Stockholders Equity |
StockholdersEquity
|
$468.13M | USD | Point-in-time |
| Total Stockholders Equity |
StockholdersEquity
|
$296.85M | USD | Point-in-time |
| Total Stockholders Equity |
StockholdersEquity
|
$483.15M | USD | Point-in-time |
| Total Liabilities, Redeemable Noncontrolling Interest and Stockholders Equity |
LiabilitiesAndStockholdersEquity
|
$579.17M | USD | Point-in-time |
| Total Liabilities, Redeemable Noncontrolling Interest and Stockholders Equity |
LiabilitiesAndStockholdersEquity
|
$587.40M | USD | Point-in-time |
Income Statement
52 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Common stock, par value (in usd per share) |
CommonStockParOrStatedValuePerShare
|
- | USD | Point-in-time |
| Common stock, par value (in usd per share) |
CommonStockParOrStatedValuePerShare
|
- | USD | Point-in-time |
| Precision oncology testing |
RevenuefromPrecisionOncologyTesting
|
$28.84M | USD | 1 Quarter |
| Common stock, shares authorized (shares) |
CommonStockSharesAuthorized
|
350.00M | shares | Point-in-time |
| Precision oncology testing |
RevenuefromPrecisionOncologyTesting
|
$14.19M | USD | 1 Quarter |
| Common stock, shares authorized (shares) |
CommonStockSharesAuthorized
|
350.00M | shares | Point-in-time |
| Common stock, shares outstanding (shares) |
CommonStockSharesOutstanding
|
86.10M | shares | Point-in-time |
| Development services |
RevenuefromDevelopmentServices
|
$7.82M | USD | 1 Quarter |
| Development services |
RevenuefromDevelopmentServices
|
$2.50M | USD | 1 Quarter |
| Common stock, shares outstanding (shares) |
CommonStockSharesOutstanding
|
85.83M | shares | Point-in-time |
| Total revenue |
Revenues
|
$16.69M | USD | 1 Quarter |
| Common stock, shares issued (shares) |
CommonStockSharesIssued
|
86.10M | shares | Point-in-time |
| Total revenue |
Revenues
|
$36.66M | USD | 1 Quarter |
| Common stock, shares issued (shares) |
CommonStockSharesIssued
|
85.83M | shares | Point-in-time |
| Variable interest entity, assets |
VariableInterestEntityConsolidatedCarryingAmountAssets
|
$47.00M | USD | Point-in-time |
| Variable interest entity, assets |
VariableInterestEntityConsolidatedCarryingAmountAssets
|
$48.30M | USD | Point-in-time |
| Variable interest entity, liabilities |
VariableInterestEntityConsolidatedCarryingAmountLiabilities
|
$942.00K | USD | Point-in-time |
| Cost of precision oncology testing |
CostsofPrecisionOncologyTesting
|
$8.04M | USD | 1 Quarter |
| Cost of precision oncology testing |
CostsofPrecisionOncologyTesting
|
$11.02M | USD | 1 Quarter |
| Variable interest entity, liabilities |
VariableInterestEntityConsolidatedCarryingAmountLiabilities
|
$1.20M | USD | Point-in-time |
| Cost of development services |
CostofDevelopmentServices
|
$1.21M | USD | 1 Quarter |
| Cost of development services |
CostofDevelopmentServices
|
$2.51M | USD | 1 Quarter |
| Research and development expense |
ResearchAndDevelopmentExpense
|
$8.26M | USD | 1 Quarter |
| Research and development expense |
ResearchAndDevelopmentExpense
|
$16.32M | USD | 1 Quarter |
| Sales and marketing expense |
SellingAndMarketingExpense
|
$11.31M | USD | 1 Quarter |
| Sales and marketing expense |
SellingAndMarketingExpense
|
$17.81M | USD | 1 Quarter |
| General and administrative expense |
GeneralAndAdministrativeExpense
|
$6.52M | USD | 1 Quarter |
| General and administrative expense |
GeneralAndAdministrativeExpense
|
$12.66M | USD | 1 Quarter |
| Total costs and operating expenses |
CostsAndExpenses
|
$35.34M | USD | 1 Quarter |
| Total costs and operating expenses |
CostsAndExpenses
|
$60.32M | USD | 1 Quarter |
| Loss from operations |
OperatingIncomeLoss
|
$-18.65M | USD | 1 Quarter |
| Loss from operations |
OperatingIncomeLoss
|
$-23.66M | USD | 1 Quarter |
| Interest income |
InvestmentIncomeInterest
|
$985.00K | USD | 1 Quarter |
| Interest income |
InvestmentIncomeInterest
|
$2.48M | USD | 1 Quarter |
| Interest expense |
InterestExpense
|
$293.00K | USD | 1 Quarter |
| Interest expense |
InterestExpense
|
$331.00K | USD | 1 Quarter |
| Other income (expense), net |
OtherNonoperatingIncomeExpense
|
$147.00K | USD | 1 Quarter |
| Other income (expense), net |
OtherNonoperatingIncomeExpense
|
$4.15M | USD | 1 Quarter |
| Loss before provision for income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$-21.32M | USD | 1 Quarter |
| Loss before provision for income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$-13.84M | USD | 1 Quarter |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$26.00K | USD | 1 Quarter |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
- | USD | 1 Quarter |
| Net loss |
ProfitLoss
|
$-13.84M | USD | 1 Quarter |
| Net loss |
ProfitLoss
|
$-21.35M | USD | 1 Quarter |
| Fair value adjustment of redeemable noncontrolling interest |
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
|
- | USD | 1 Quarter |
| Fair value adjustment of redeemable noncontrolling interest |
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
|
$4.70M | USD | 1 Quarter |
| Net loss attributable to Guardant Health, Inc. common stockholders |
NetIncomeLossAvailableToCommonStockholdersBasic
|
$-13.84M | USD | 1 Quarter |
| Net loss attributable to Guardant Health, Inc. common stockholders |
NetIncomeLossAvailableToCommonStockholdersBasic
|
$-26.05M | USD | 1 Quarter |
| Net loss per share attributable to common stockholders, basic and diluted (in usd per share) |
EarningsPerShareBasicAndDiluted
|
$-1.16 | USD | 1 Quarter |
| Net loss per share attributable to common stockholders, basic and diluted (in usd per share) |
EarningsPerShareBasicAndDiluted
|
$-0.30 | USD | 1 Quarter |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted (in shares) |
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
85.94M | shares | 1 Quarter |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted (in shares) |
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
11.92M | shares | 1 Quarter |
Cash Flow Statement
72 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net loss |
ProfitLoss
|
$-13.84M | USD | 1 Quarter |
| Net loss |
ProfitLoss
|
$-21.35M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$1.40M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$2.35M | USD | 1 Quarter |
| Unrealized translation (gains) losses on obligation related to royalty |
UnrealizedTranslationsGainLossOnObligationRelatedToRoyalty
|
$-206.00K | USD | 1 Quarter |
| Unrealized translation (gains) losses on obligation related to royalty |
UnrealizedTranslationsGainLossOnObligationRelatedToRoyalty
|
$144.00K | USD | 1 Quarter |
| Non-cash stock-based compensation |
ShareBasedCompensation
|
$1.28M | USD | 1 Quarter |
| Non-cash stock-based compensation |
ShareBasedCompensation
|
$3.18M | USD | 1 Quarter |
| Non-cash interest expense |
NoncashInterestExpensePaid
|
- | USD | 1 Quarter |
| Non-cash interest expense |
NoncashInterestExpensePaid
|
$3.00K | USD | 1 Quarter |
| Amortization of discounts on marketable securities |
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
$78.00K | USD | 1 Quarter |
| Amortization of discounts on marketable securities |
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
$553.00K | USD | 1 Quarter |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$-623.00K | USD | 1 Quarter |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$-11.61M | USD | 1 Quarter |
| Inventory |
IncreaseDecreaseInInventories
|
$-321.00K | USD | 1 Quarter |
| Inventory |
IncreaseDecreaseInInventories
|
$1.12M | USD | 1 Quarter |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$1.31M | USD | 1 Quarter |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$947.00K | USD | 1 Quarter |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$833.00K | USD | 1 Quarter |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$-255.00K | USD | 1 Quarter |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$-2.61M | USD | 1 Quarter |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$1.99M | USD | 1 Quarter |
| Accrued compensation |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$-608.00K | USD | 1 Quarter |
| Accrued compensation |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$1.70M | USD | 1 Quarter |
| Accrued expenses and other current liabilities |
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
$2.31M | USD | 1 Quarter |
| Accrued expenses and other current liabilities |
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
$1.11M | USD | 1 Quarter |
| Deferred rent |
IncreaseDecreaseInDeferredCharges
|
$-621.00K | USD | 1 Quarter |
| Deferred rent |
IncreaseDecreaseInDeferredCharges
|
$-1.13M | USD | 1 Quarter |
| Deferred revenue |
IncreaseDecreaseInDeferredRevenue
|
$975.00K | USD | 1 Quarter |
| Deferred revenue |
IncreaseDecreaseInDeferredRevenue
|
$1.49M | USD | 1 Quarter |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-6.56M | USD | 1 Quarter |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-4.30M | USD | 1 Quarter |
| Purchase of marketable securities |
PaymentsToAcquireMarketableSecurities
|
$45.97M | USD | 1 Quarter |
| Purchase of marketable securities |
PaymentsToAcquireMarketableSecurities
|
$19.63M | USD | 1 Quarter |
| Maturity of marketable securities |
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
$32.12M | USD | 1 Quarter |
| Maturity of marketable securities |
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
$64.00M | USD | 1 Quarter |
| Purchase of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$4.02M | USD | 1 Quarter |
| Purchase of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$2.71M | USD | 1 Quarter |
| Net cash provided by investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$8.47M | USD | 1 Quarter |
| Net cash provided by investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$15.33M | USD | 1 Quarter |
| Payments made on royalty obligations |
PaymentRelatedtoSettlementofDebtandBuyoutofRoyaltyObligations
|
$73.00K | USD | 1 Quarter |
| Payments made on royalty obligations |
PaymentRelatedtoSettlementofDebtandBuyoutofRoyaltyObligations
|
- | USD | 1 Quarter |
| Payments made on capital lease obligations |
RepaymentsOfLongTermCapitalLeaseObligations
|
$21.00K | USD | 1 Quarter |
| Payments made on capital lease obligations |
RepaymentsOfLongTermCapitalLeaseObligations
|
$47.00K | USD | 1 Quarter |
| Proceeds from issuance of common stock upon exercise of stock options |
ProceedsFromStockOptionsExercised
|
$538.00K | USD | 1 Quarter |
| Proceeds from issuance of common stock upon exercise of stock options |
ProceedsFromStockOptionsExercised
|
$1.31M | USD | 1 Quarter |
| Proceeds from issuance of common stock upon the exercise of warrants |
ProceedsFromWarrantExercises
|
- | USD | 1 Quarter |
| Proceeds from issuance of common stock upon the exercise of warrants |
ProceedsFromWarrantExercises
|
$4.00K | USD | 1 Quarter |
| Proceeds from issuances of common stock under employee stock purchase plan |
ProceedsFromStockPlans
|
$1.93M | USD | 1 Quarter |
| Proceeds from issuances of common stock under employee stock purchase plan |
ProceedsFromStockPlans
|
- | USD | 1 Quarter |
| Payment of offering costs related to initial public offering |
PaymentsOfStockIssuanceCosts
|
- | USD | 1 Quarter |
| Payment of offering costs related to initial public offering |
PaymentsOfStockIssuanceCosts
|
$89.00K | USD | 1 Quarter |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$1.27M | USD | 1 Quarter |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$2.29M | USD | 1 Quarter |
| Net effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$-69.00K | USD | 1 Quarter |
| Net effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
- | USD | 1 Quarter |
| Net increase in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$13.24M | USD | 1 Quarter |
| Net increase in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$3.18M | USD | 1 Quarter |
| Cash, cash equivalents and restricted cash - Beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$140.54M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash - Beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$153.79M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash - Beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$75.77M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash - Beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$72.60M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash - End of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$140.54M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash - End of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$153.79M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash - End of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$75.77M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash - End of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$72.60M | USD | Point-in-time |
| Cash paid for interest |
InterestPaidNet
|
$293.00K | USD | 1 Quarter |
| Cash paid for interest |
InterestPaidNet
|
$30.00K | USD | 1 Quarter |
| Cash paid for income taxes |
IncomeTaxesPaidNet
|
$-48.00K | USD | 1 Quarter |
| Cash paid for income taxes |
IncomeTaxesPaidNet
|
- | USD | 1 Quarter |
| Purchases of property and equipment included in accounts payable and accrued expenses |
IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid
|
$3.35M | USD | 1 Quarter |
| Purchases of property and equipment included in accounts payable and accrued expenses |
IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid
|
$490.00K | USD | 1 Quarter |
Stockholders Equity
21 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Fair value adjustment of redeemable noncontrolling interest |
ReclassificationsOfTemporaryToPermanentEquity
|
$-4.70M | USD | 1 Quarter |
| Beginning balance |
StockholdersEquity
|
$308.61M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$468.13M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$296.85M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$483.15M | USD | Point-in-time |
| Issuance of common stock upon exercise of stock options, shares |
StockIssuedDuringPeriodSharesStockOptionsExercised
|
146,318.00 | shares | 1 Quarter |
| Issuance of common stock upon exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$1.10M | USD | 1 Quarter |
| Issuance of common stock upon exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$538.00K | USD | 1 Quarter |
| Vesting of common stock exercised early |
StockIssuedDuringPeriodValueStockOptionsExercisedEarly
|
$56.00K | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$3.18M | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$1.28M | USD | 1 Quarter |
| Common stock issued under employee stock purchase plan |
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
$1.93M | USD | 1 Quarter |
| Issuance of common stock upon exercise of warrants |
StockIssuedDuringPeriodValueExerciseofWarrants
|
$4.00K | USD | 1 Quarter |
| Other comprehensive gain (loss), net of tax impact |
OtherComprehensiveIncomeLossNetOfTax
|
$-298.00K | USD | 1 Quarter |
| Other comprehensive gain (loss), net of tax impact |
OtherComprehensiveIncomeLossNetOfTax
|
$416.00K | USD | 1 Quarter |
| Net loss |
ProfitLoss
|
$-13.84M | USD | 1 Quarter |
| Net loss |
ProfitLoss
|
$-21.35M | USD | 1 Quarter |
| Ending balance |
StockholdersEquity
|
$308.61M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$468.13M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$296.85M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$483.15M | USD | Point-in-time |
Comprehensive Income
14 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net loss |
ProfitLoss
|
$-13.84M | USD | 1 Quarter |
| Net loss |
ProfitLoss
|
$-21.35M | USD | 1 Quarter |
| Unrealized gain (loss) on available-for-sale securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-298.00K | USD | 1 Quarter |
| Unrealized gain (loss) on available-for-sale securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$485.00K | USD | 1 Quarter |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
$-69.00K | USD | 1 Quarter |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
- | USD | 1 Quarter |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-298.00K | USD | 1 Quarter |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$416.00K | USD | 1 Quarter |
| Comprehensive loss |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$-14.14M | USD | 1 Quarter |
| Comprehensive loss |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$-20.93M | USD | 1 Quarter |
| Comprehensive loss attributable to redeemable noncontrolling interest |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
|
$4.70M | USD | 1 Quarter |
| Comprehensive loss attributable to redeemable noncontrolling interest |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
|
- | USD | 1 Quarter |
| Comprehensive loss attributable to Guardant Health, Inc. |
ComprehensiveIncomeNetOfTax
|
$-14.14M | USD | 1 Quarter |
| Comprehensive loss attributable to Guardant Health, Inc. |
ComprehensiveIncomeNetOfTax
|
$-25.64M | USD | 1 Quarter |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.